A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...

U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma giant to sidestep over 200 complaints alleging the ...

Kennedy Jr., can take immediate action as part of his prioritization of “radical transparency” to aid his mission ... died from the anti-inflammatory drug Vioxx, after pharmaceutical company Merck hid ...

Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a new version of its crucial cancer drug Keytruda. Enzyme Dispute ...

Pharmaceutical companies control and hide ... can take immediate action as part of his prioritization of “radical transparency” to aid his mission to “Make America Healthy Again.” ...

A dispute over a microscopic enzyme is threatening Merck & Co. plans to sell a new version of Keytruda, the cancer drug that generates nearly half of the company’s sales. Merck has been tweaking ...

Merck now finds itself in the same precarious position that has tripped up other pharma giants: when one product becomes a major hit. Keytruda accounts for about 45% of total revenue, raking in $ ...

Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...